Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab (Tecentriq) in Local Head and Neck Squamous Cell Carcinoma (the PIONEER Trial)

X
Trial Profile

Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab (Tecentriq) in Local Head and Neck Squamous Cell Carcinoma (the PIONEER Trial)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atezolizumab (Primary) ; Simlukafusp alfa (Primary)
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Acronyms PIONEER; the PIONEER Trial
  • Most Recent Events

    • 24 Apr 2024 Status changed from recruiting to completed.
    • 13 Apr 2024 This trial has been Discontinued in Germany, according to European Clinical Trials Database record.
    • 10 Aug 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top